Benztropine Mesylate 10135-0813
Product NDC
10135-0813- Manufacturer
- Marlex Pharmaceutical, Inc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 1, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA204713
Need to source Benztropine Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Benztropine Mesylate | .5 mg/1 |
Drug Class
Anticholinergic [EPC]Antihistamine [EPC]Cholinergic Antagonists [MoA]
Packaging Options(2)
100 TABLET in 1 BOTTLE (10135-813-01)
1000 TABLET in 1 BOTTLE (10135-813-10)